Journey Medical NASDAQ DERM Reports 21 Revenue Growth in Q1 2026 Remains Unprofitable Perpetualscom PDC Falls 172 Watching 679 Support 20260514 Invivyd Flags Going Concern Risk as Biotech Firm Navigates Deepening Losses